Dopamine Agents (pharmacokinetics) < Dopamine Agents (pharmacology) < Dopamine Agents (therapeutic use)

Facettes :

List of bibliographic references indexed by Dopamine Agents (pharmacology)

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]

Ident.	Authors (with country if any)	Title
000314 (2016)	F. Pieruccini-Faria [Canada] ; J A Jones [Canada] ; Q J Almeida [Canada]	Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
000474 (2015)	Tiago A. Mestre [Canada] ; Isabelle Beaulieu-Boire [Canada] ; Camila C. Aquino [Canada] ; Nicolas Phielipp [États-Unis] ; Yu Yan Poon [Canada] ; Jane P. Lui [Canada] ; Julie So [Canada] ; Susan H. Fox [Canada]	What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease?
000505 (2015)	Matt J N. Brown [Canada] ; Quincy J. Almeida ; Fariborz Rahimi	The dopaminergic system in upper limb motor blocks (ULMB) investigated during bimanual coordination in Parkinson's disease (PD).
000522 (2015)	Tom M. Johnston [Canada] ; Susan H. Fox	Symptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human Primates.
000687 (2015)	David Mongeon [Canada] ; Pierre Blanchet ; Stéphanie Bergeron ; Julie Messier	Impact of Parkinson's disease on proprioceptively based on-line movement control.
000904 (2014)	Magda Osman [Royaume-Uni] ; Agata Ryterska [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; Lingling Tu [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]	The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
000933 (2014)	Sherri L. Thiele [Canada] ; Betty Chen [Canada] ; Charlotte Lo [Canada] ; Tracey S. Gertler [États-Unis] ; Ruth Warre [Canada] ; James D. Surmeier [États-Unis] ; Jonathan M. Brotchie [Canada] ; Joanne E. Nash [Canada]	Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models
000D97 (2013)	Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard ; Quincy J. Almeida	Dopaminergic contributions to distance estimation in Parkinson's disease: a sensory-perceptual deficit?
001473 (2012)	Alain Dagher [Canada]	ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE
001538 (2012)	Aimee J. Nelson [Canada] ; Azra Premji [Canada] ; Navjot Rai [Canada] ; Tasnuva Hoque [Canada] ; Mark Tommerdahl [États-Unis] ; Robert Chen [Canada]	Dopamine Alters Tactile Perception in Parkinson's Disease
001A25 (2010)	Wing-Lok Au [Singapour] ; Ni Lei ; Meeko M K. Oishi ; Martin J. Mckeown	L-dopa induces under-damped visually guided motor responses in Parkinson's disease.
001D97 (2009)	Moran Weinberger [Canada] ; William D. Hutchison ; Jonathan O. Dostrovsky	Pathological subthalamic nucleus oscillations in PD: can they be the cause of bradykinesia and akinesia?
002096 (2009)	D. Mongeon [Canada] ; P. Blanchet [Canada] ; J. Messier [Canada]	IMPACT OF PARKINSON'S DISEASE AND DOPAMINERGIC MEDICATION ON PROPRIOCEPTIVE PROCESSING
002305 (2008)	Philip Seeman [Canada] ; Carla Caruso [Argentine] ; Mercedes Lasaga [Argentine]	Memantine agonist action at dopamine D2High receptors
002429 (2007)	Mojgan Hodaie [Canada] ; Joseph S. Neimat ; Andres M. Lozano	The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
002914 (2006)	Carl Julien [Canada] ; Line Berthiaume [Canada] ; Abdallah Hadj-Tahar [Canada] ; Ali H. Rajput [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] ; Pierre Julien [Canada] ; Frédéric Calon [Canada]	Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys
002D83 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire ; Paul Bédard ; Thérèse Di Paolo	Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
002D89 (2003)	Patrice D. Smith [Canada] ; Stephen J. Crocker [Canada] ; Vernice Jackson-Lewis ; Kelly L. Jordan-Sciutto [États-Unis] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Michael J. O'Hare [Canada] ; Steven Callaghan [Canada] ; Ruth S. Slack [Canada] ; Serge Przedborski [États-Unis] ; Hymie Anisman [Canada] ; David S. Park [Canada]	Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
003095 (2002)	Ron Levy [Canada] ; Peter Ashby [Canada] ; William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada]	Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease
003363 (2000)		Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
003867 (1998)	M. Morissette ; M. Goulet ; R. Grondin ; P. Blanchet ; P J Bédard ; T. Di Paolo ; D. Lévesque	Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Agents (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Agents (pharmacology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022